Pillstats
Rx only · Tablet, Film Coated · Oral

Erythromycin

Erythromycin

13 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US26 NDCs
13 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCD10AF02
RxCUI (US)4053
US makers13 labelers
Packages67
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 15 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.636$1.27$1.91$2.54Dec 2025Apr 2026Jul 2026
$2.209
Latest avg · Jul 22, 2026
+4%
Since Dec 17, 2025
13
Active US suppliers
30%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.1K2.3K3.4K4.5K2025 Q12025 Q22025 Q32025 Q42026 Q1
2.2K
Rx · 2026 Q1
114K
Units dispensed
-35%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it13 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Alembic Pharmaceuticals Limitedunknown12SUPPLYING
Ascend Laboratories, LLCunknown8SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown6SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown6SUPPLYING
Zydus Lifesciences Limitedunknown6SUPPLYING
Modavar Pharmaceuticals LLCunknown4SUPPLYING
Arbor Pharmaceuticals, Inc.unknown4SUPPLYING
Nivagen Pharmaceuticals, Inc.unknown4SUPPLYING
Cadila Pharmaceuticals Limitedunknown4SUPPLYING
Orange Pharmaceuticals USA LLCunknown4SUPPLYING
Wilshire Pharmaceuticals, Inc.unknown4SUPPLYING
PD-Rx Pharmaceuticals, Inc.unknown3SUPPLYING
A-S Medication Solutionsunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 29, 2026
    RECALLRecall (Class II): Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad,…

    CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide within the U.S

  • Apr 29, 2026
    RECALLRecall (Class II): Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad,…

    CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit — Recalling firm: Zydus Pharmaceuticals (USA) Inc — Nationwide within the U.S